| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
OPP-EBV-CAD regimen
1
relevant articles (1 outcomes,
0 trials/studies)
found for this Bio-Agent
Description: chemotherapy protocol consisting of above compounds and procarbazine, vinblastine and bleomycin used in treatment of advanced refractory or resistant multiple myeloma
Also Known As:OPPEBVCAD regimen
Relationship Network
Bio-Agent Context: Research Results
Related Diseases
| 1. | Hodgkin Disease (Hodgkin's Disease)
12/01/2000
- "With the aim of developing an effective therapy for heavily pretreated refractory MM outpatients, we evaluated the OPPEBVCAD regimen, a Hodgkin's disease-derived protocol that includes many drugs effective in MM administered in a sequential schedule. "
Order ALL the reference details at left... |
| 2. | Multiple Myeloma
12/01/2000
- "OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma."
Order ALL the reference details at left... |
Best Treatments:
Research Summary Report
on Hodgkin Disease
Research Summary Report
on Hodgkin Disease
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
- Free Updates for 1 Year
- All 656 Outcomes
- Top 200 Key Drugs and Biologics
- Top 50 Key Therapies and Procedures
- Detailed History Charts
- Full Research Reference Details
- Sample PDF Report on Psoriasis >>
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
Research Interface
- Unlimited Disease, Drug and Therapy Search
- 2 clicks from Disease to Drug to Evidence
- Trial References
- All the Positive Outcomes
- Detailed Relationship Timeline Charts
- Full Article Reference Details
- Includes Mobile Interface Subscription
- One-click to FDA Products/Patents
- Request Institution License Details >>
| Price: | $490.00
access via web interface 1 year subscription |
Mobile Interface
- Access from any web enabled PDA or Phone
- Trial references
- All the Positive Outcomes
- Drug and Therapy searches
- Full Article Reference Details
- Try Mobile Interface >>
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |